Market Research Future

Cancer Biological Therapy Market to Grow at CAGR of 4.7% Till 2023

Global Cancer Biological Therapy Market Information; By Phases (Phase I, Phases II and Phases III); by Type (Monoclonal Antibodies, Interferon’s, Interleukins, Cancer growth inhibitors, Gene Therapy and Colony-Stimulating Factors); by End-Users (Hospitals & Clinics, Cancer Research Centers, Laboratories) - Forecast to 2023


Pune, India -- (SBWIRE) -- 07/11/2017 -- Market Highlights

Cancer is the leading and second largest cause of death across the globe. The disease is characterized by disordered and deregulated cellular and stromal explosion along with reduced cell death and growth factor deprivation, and such other factors.

Biological therapy treatment is done with the help of living organisms, parts of living organisms or laboratory manufactured version of such content. Most of the biological therapies use bacteria or vaccines to mimic the body's immune system to act against cancer developing cells. These various types of biological therapies, which are most of the times stated to biological response modifier therapy or immunotherapy, but these types of therapies do not always target cancer cells directly. Further there are other biological therapies like sections of genetic material or antibodies which are commonly known as DNA or RNA, do aim at targeting cancer cells directly. There are also other types of biological therapies that inhibit specific molecules involved in development and growth of cancer tumor. Such therapies known as; cancer targeted therapies.

Get a Copy of Sample Report @

Market Players:

-Amgen Inc.,
-Bristol-Myers Squibb,
-Celgene Corporation,
-ELI Lilly and Company,
-F. Hoffmann-La Roche AG,
-EnGeneIC Ltd,
-Merck & Co., Inc.,
-Novartis,Pfizer Inc.


The global Cancer Biological Therapy market is segmented on the basis of phases. Based on the phases, the market has been segmented as phase I, phases II and phases III. Based on the type, the market has been segmented as monoclonal antibodies, interferons, interleukins, cancer growth inhibitors, gene therapy and colony-stimulating factors. Based on the end-users, the market has been segmented as hospitals & clinics, cancer research centers and laboratories.

Test the market data and market information presented through more than 50 market data tables and figures spread over 80 numbers of pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on "Global Cancer Biological Therapy Market" Research Report – Forecast to 2023."

Report Details @

Intended Audience

-Global Cancer Biological Therapy solutions providers, manufacturers & suppliers
-Research and development (R&D) companies
-Market research and consulting service providers
-Academic institutes and universities

Regional analysis

US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. Europe is the second largest market due to large disposable income and rising awareness. Asia pacific region will be the fastest region because of large unmet needs which will be led by China and India. The Middle East and Africa market will be led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa is expected to be a laggard due to poor economic and political conditions.

Table of Content

1 Report Prologue
2 Introduction
2.1 Definition
2.2 Scope of Study:
2.3 Research Objective
2.4 Market Structure
3 Research Process:
3.1.1 Primary Research:
3.1.2 Secondary Research:
4 Market
4.1 Introduction
4.2 Drivers
4.2.1 Increasing Cancer Survival Rate
4.2.2 Growing Demand for Advanced Therapies

Browse Related Statistical Reports

The global micro-pump market by industry is expected to grow at a rate of 9.3% during the forecasted period. Pharmaceutical industry segment commands the largest market share of 54.6% of total market and is expected to reach at USD 2,998.9 million by 2027.

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact Info:
Name: Akash Anand
Organization: Market Research Future
Address: Market Research Future Office No. 524/528,
Phone: +1 646 845 9312